Evaluation of the Strategy of "One-stop" Endovascular Treatment for Concomitant Coronary Artery Disease and Aortic Atherosclerotic Disease
- Conditions
- Coronary Artery DiseaseAortic Atherosclerotic Disease
- Interventions
- Procedure: One-stop strategy group
- Registration Number
- NCT03563768
- Lead Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Brief Summary
The study is a prospective, randomized, controlled, exploratory trail to evaluate the strategy of "one-stop" endovascular treatment for concomitant coronary artery disease and aortic atherosclerotic disease.
- Detailed Description
60 patients will be allocated randomly in a 1:1 ratio into one-stop strategy group or staging strategy group. In one-stop strategy group, percutaneous coronary intervention (PCI) will be performed on the same operating room immediately after the endovascular aortic repair (EVAR); In staging strategy group, PCI will be performed several days after EVAR. The safety and effectiveness will be assessed between two groups 1 year after the operation. The economic index will be evaluated as well as.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- Aged from 18 years to 75years, male or female;
- Aortic atherosclerotic disease with indication of EVAR;
- Coronary heart disease with indication of PCI;
- Provided informed consent.
- Acute aortic dissection
- Acute coronary syndrome
- Dysfunction of coagulation system
- Patients with gastrointestinal hemorrhage
- Known allergy to contrasts or antiplatelet drugs
- Renal dysfunction (GFR≤60ml/min)
- Patient with multi-branch coronary preferred CABG
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description One-stop strategy group One-stop strategy group Percutaneous coronary intervention (PCI) will be performed on the same operating table immediately after the endovascular aortic repair (EVAR)
- Primary Outcome Measures
Name Time Method Perioperative major bleeding (BARC≥3 grade) 12 months
- Secondary Outcome Measures
Name Time Method Difference of incidence of bleeding events (BARC 2 grade) between two groups 12 months Difference of incidence of all-cause death between two groups 12 months Difference of incidence of myocardial infarction between two groups 12 months Difference of operative success rate between two groups 12 months Difference of incidence of Stent thrombosis between two groups 12 months Composite of average in-patient time and average cost during hospitalization 12 months Difference of incidence of rupture of aorta between two groups 12 months Difference of incidence of pseudoaneurysm between two groups 12 months
Trial Locations
- Locations (1)
Chinese Academy of Medical Sciences, Fuwai Hospital
🇨🇳Beijing, Beijing, China